References
- Korea Disease Control and Prevention Agency (KDCA). https://health.kdca.go.kr/healthinfo/biz/health/gnrlzHealthInfo/gnrlzHealthInfo/gnrlzHealthInfoView.do?cntnts_sn=5427. (2021.07.09).
- Wang, H. et al. Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. 62, 294-296 (1999). https://doi.org/10.1021/np980501m
- Parker, H. M. et al. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. 56, 944-951 (2012). https://doi.org/10.1016/j.jhep.2011.08.018
- Feher, J. & Lengyel, G. J. C. p. b. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. 13, 210-217 (2012). https://doi.org/10.2174/138920112798868818
- Ipsen, D. H., Tveden-Nyborg, P. & Lykkesfeldt, J. J. N. Does vitamin C deficiency promote fatty liver disease development? 6, 5473-5499 (2014). https://doi.org/10.3390/nu6125473
- Lawrence, R. A., Burk, R. F. J. B. & communications, b. r. Glutathione peroxidase activity in selenium-deficient rat liver. 71, 952-958 (1976). https://doi.org/10.1016/0006-291X(76)90747-6